Murphy Polly A. — SEC Form 4 filings
SEC reporting owner CIK 1829248. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-06 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 12,200 shares, $50,892 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: purchase of 6,100 shares @ $4.17 ($25,446) in Atea Pharmaceuticals, Inc., filed 2026-05-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | Director | 6 | 2 legs · 12,200 sh · $50,892 | — | 12 |
| Celcuity Inc. (CELC) | Director | 5 | — | — | 11 |
Form 4 filings — Murphy Polly A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Celcuity Inc. (CELC) | Gift (G): 14,048 (derivative) @ $0 · Gift (G): 14,048 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Celcuity Inc. (CELC) | Grant/award (A): 1,530 @ $0 | EDGAR |
| 2026-05-21 | 4/A | Atea Pharmaceuticals, Inc. (AVIR) | Purchase (P): 6,100 @ $4.17 | EDGAR |
| 2026-05-20 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Purchase (P): 6,100 @ $4.17 | EDGAR |
| 2025-06-24 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Celcuity Inc. (CELC) | Gift (G): 16,300 (derivative) @ $0 · Gift (G): 16,300 (derivative) @ $0 · Gift (G): 11,645 (derivative) @ $0 · Gift (G): 11,645 (derivative) @ $0 · Gift (G): 8,153 (derivative) @ $0 · Gift (G): 8,153 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Celcuity Inc. (CELC) | Grant/award (A): 14,048 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Celcuity Inc. (CELC) | Grant/award (A): 8,153 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829248 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →